胶质瘤CpG岛甲基化表型(G-CIMP):生物学与临床意义
本文综述胶质瘤CpG岛甲基化表型(G-CIMP)的生物学与临床意义。2016年WHO中枢神经系统肿瘤分类建议对胶质瘤进行异柠檬酸脱氢酶(IDH)突变状态的分子诊断,IDH突变型胶质瘤表现为G-CIMP。新近识别的G-CIMP-high与G-CIMP-low亚型可独立于分级和组织学进一步细化胶质瘤分类,可能有助于预测患者结局并转化为个体化治疗策略。
要点
- 2016年WHO分类建议对胶质瘤进行IDH突变状态的分子诊断。
- IDH突变型胶质瘤表现为CpG岛甲基化表型(G-CIMP)。
- G-CIMP-high与G-CIMP-low亚型可独立于分级和组织学细化分类。
核心结论
- G-CIMP-high与G-CIMP-low亚型可独立于分级和组织学进一步细化胶质瘤分类,可能有助于预测患者结局并转化为个体化治疗策略。
研究设计与样本
- 本文为综述,梳理对G-CIMP亚型认识的发展,以及胶质瘤基因组与表观基因组表征进展对未来基础与转化研究的影响。
主要发现
- 2016年WHO中枢神经系统肿瘤分类整合基因型与表型特征以细化肿瘤诊断并缩窄定义亚组。
- 2016年WHO分类建议对胶质瘤进行IDH突变状态的分子诊断。
- IDH突变型胶质瘤表现为CpG岛甲基化表型(G-CIMP)。
- 新近识别的G-CIMP-high与G-CIMP-low亚型可独立于分级和组织学进一步细化胶质瘤分类。
关键数值与推荐
- 2016年WHO分类建议对胶质瘤进行IDH突变状态的分子诊断。
- IDH突变型胶质瘤表现为G-CIMP。
- G-CIMP-high与G-CIMP-low亚型可独立于分级和组织学进一步细化胶质瘤分类。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Gliomas are a heterogeneous group of brain tumors with distinct biological and clinical properties. Despite advances in surgical techniques and clinical regimens, treatment of high-grade glioma remains challenging and carries dismal rates of therapeutic success and overall survival. Challenges include the molecular complexity of gliomas, as well as inconsistencies in histopathological grading, resulting in an inaccurate prediction of disease progression and failure in the use of standard therapy. The updated 2016 World Health Organization (WHO) classification of tumors of the central nervous system reflects a refinement of tumor diagnostics by integrating the genotypic and phenotypic features, thereby narrowing the defined subgroups. The new classification recommends molecular diagnosis of isocitrate dehydrogenase (IDH) mutational status in gliomas. IDH-mutant gliomas manifest the cytosine-phosphate-guanine (CpG) island methylator phenotype (G-CIMP). Notably, the recent identification of clinically relevant subsets of G-CIMP tumors (G-CIMP-high and G-CIMP-low) provides a further refinement in glioma classification that is independent of grade and histology. This scheme may be useful for predicting patient outcome and may be translated into effective therapeutic strategies tailored to each patient. In this review, we highlight the evolution of our understanding of the G-CIMP subsets and how recent advances in characterizing the genome and epigenome of gliomas may influence future basic and translational research.
引用
- Malta TM, de Souza CF, Sabedot TS, et al. Glioma CpG island methylator phenotype (G-CIMP): biological and clinical implications. Neuro Oncol. 2018. PMID: 29036500. doi:10.1093/neuonc/nox183
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。